EU Green Regulations Impact Pharmaceutical Chemical Industry
Pharma specialty chemicals companies have been experiencing serious challenges based on the greening regulations enforced by the European Union. Such regulatory systems promote the harmonization of environmental stewardship and industrial development, yet they have become complex for the specialty chemical makers of compounds fundamental to pharmaceutical production. Foremost among these are the REACH (Registration, Evaluation, […]
Meribel Pharma Solutions launches with big ambitions to elevate pharma services to new heights
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network across Europe, led by a team of industry experts on a mission to deliver the highest quality solutions and services to enable customers to scale to new heights and improve patient health. The firm has ten manufacturing […]
Berry to Showcase Latest Technologies for Fast-to-Market, Patient-Centric Solutions
Solutions for patient-centred drug delivery devices that enhance dosing, administration, and medication adherence will be the focus of Berry Global Healthcare’s participation at this year’s RDD (Respiratory Drug Delivery) Europe Conference, taking place at the Estoril Congress Centre, Estoril (Lisbon), Portugal from May 6th to 9th. The company’s Medical Devices team will present a wide […]
Rapid Screening-Differential Scanning Calorimeter for Antibody Drug Development
Ensuring the thermal balance and stability of an antibody drug product happens to be quite critical when it comes to maintaining quality and at the same time securing regulatory nod. The Rapid Screening-Differential Scanning Calorimeter (RS-DSC) from TA Instruments™ offers an effective solution to screen any sort of buffer formulations and also assess protein sequence […]
Pharmaceutical Documentation Enters a New Era of Innovation
The future of pharmaceutical documentation is here – faster, smarter and compliant. That’s what World Pharma Today learnt from its recent interview with Docuvera. Striking the right chord between regulatory compliance and automation, Docuvera has indeed changed the way pharmaceutical documentation is being analyzed and executed. 1. How does Docuvera’s AI-driven approach transform the erstwhile traditional pharmaceutical […]
How Language Barriers Impact Non-Native English Speakers in Healthcare
Language barriers create significant challenges for non-native English speakers in healthcare settings. In the United States, English is the primary language, which complicates communication for non-English-speaking patients. These patients often struggle to describe symptoms, understand instructions, and navigate the healthcare system effectively. Miscommunication can lead to misdiagnosis, improper treatment, and poor health outcomes. As diversity […]
Steriline's Advanced Filling Innovations Exhibited At Interphex 2025
New York City, March 25, 2025 – Steriline, a well-established European manufacturer of highly specialized robotic filling machines and complete aseptic filling/finishing lines, will attend Interphex, the leading global pharmaceutical and biotechnology event that fosters collaborations and provides a comprehensive view of advancements in the pharmaceutical industry. The company will welcome visitors on April 1-3, 2025 at stand 2537 in the Javits Center, NYC, […]
FDA Approval of AMVUTTRA for ATTR Amyloidosis
Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics, has announced U.S. FDA approval of AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy associated with wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. This approval makes AMVUTTRA the first and only U.S. FDA-approved therapeutic to address both cardiomyopathy and polyneuropathy (hATTR-PN) in ATTR amyloidosis. ATTR-CM is […]
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC). Data from the B1 cohort of the trial showed encouraging antitumor efficacy in highly pre-treated patients with advanced ovarian cancer (OC) independent of FRα expression levels. Rina-S 120 mg/m2 Q3W showed […]
Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs
London, UK: Coronado Research has appointed Gary Lyons as EVP Medical Affairs. Gary is a seasoned senior Medical Affairs leader with extensive strategic and operational implementation experience across the industry and product lifecycle. He has previously led agency business units and built strategic teams focused on delivering outstanding medical communication services at global and local levels – […]
